• Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis. 2002;17:265–77.

  CAS PubMed  Google Scholar 

• Baudoux T, Pozdzik AA, Arlt VM, De Prez E, Quellard N, Goujon JM, Nortier JL. Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy. Kidney Int. 2012;82:1105–13.

  CAS PubMed  Google Scholar 

• Baudoux T, Husson C, De Prez E, Jadot I, Antoine M-H, Nortier J, Hougardy J-M. CD4+ and CD8+ T cells exert regulatory properties during experimental acute aristolochic acid nephropathy. Sci Rep. 2018;8:5334.https://doi.org/10.1038/s41598-018-23565-2.

  Article CAS PubMed PubMed Central  Google Scholar 

• Bunel V, Souard F, Antoine M-H, Stevigny C, Nortier JL. Nephrotoxicity of natural products: aristolochic acid and fungal toxins. In: McQueen CA, editor. Comprehensive toxicology, vol. 14. 3rd ed. Oxford: Elsevier Ltd; 2018. p. 340–79.

  Google Scholar 

• Cosyns JP, Jadoul M, Squifflet JP, De Plaen JF, Ferluga D, van Ypersele de Strihou C. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy ? Kidney Int. 1994;45:1680–8.

  CAS PubMed  Google Scholar 

• Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de Strihou C. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis. 1999;33:1011–7.

  CAS PubMed  Google Scholar 

• Cosyns JP, Dehoux JP, Guiot Y, et al. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int. 2001;59:2164–73.

  CAS PubMed  Google Scholar 

• Debelle FD, Nortier JL, De Prez EG, Vienne A, Garbar C, Salmon I, Deschodt-Lanckman M, Vanherweghem JL. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol. 2002;13:431–6.

  CAS PubMed  Google Scholar 

• Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 2008;74:158–69.

  CAS PubMed  Google Scholar 

• De Broe ME. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy. Kidney Int. 2012;81:513–5.

  PubMed  Google Scholar 

• Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis. 1994;24:172–80.

  CAS PubMed  Google Scholar 

• Duquesne M, Decleves AE, De Prez E, Nortier J, Colet JM. Interest of metabonomic approach in environmental nephrotoxicants: application to aristolochic acid exposure. Food Chem Toxicol. 2017;108:19–29.

  CAS PubMed  Google Scholar 

• El Dirdiri NI, Barakat SE, Adam SE. The combined toxicity of Aristolochia bracteata and Cadaba rotundifolia to goats. Vet Hum Toxicol. 1987;29:133–7.

  PubMed  Google Scholar 

• Gökmen MR, Cosyns JP, Arlt VM, Stiborova M, Phillips DH, Schmeiser HH, Simmonds M, Cook HT, Vanherweghem JL, Nortier JL, Lord GM. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review. Ann Intern Med. 2013;158:469–77.

  PubMed  Google Scholar 

• Grollman AP. Aristolochic acid nephropathy: harbinger of a global iatrogenic disease. Environ Mol Mutagen. 2013;54:1–7.

  CAS PubMed  Google Scholar 

• Hashimoto K, Higushi M, Makino B. Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants. J Ethnopharmacol. 1999;64:185–9.

  CAS PubMed  Google Scholar 

• Heinrich M, Chan J, Wanke S, Neinhuis C, Simmonds MSJ. Local uses of aristolochia species and content of nephrotoxic aristolochic acid 1 and 2 - a global assessment based on bibliographic sources. J Ethnopharmacol. 2009;125:108–44.

  CAS PubMed  Google Scholar 

• Ivić M. Etiology of endemic nephropathy. Lijec Vjesn. 1969;91:1273–81.

  PubMed  Google Scholar 

• Jadot I, Decleves AE, Nortier J, Caron N. An integrated view of aristolochic acid nephropathy: update of the literature. Int J Mol Sci. 2017a;18:297–319.https://doi.org/10.3390/ijms18020297.

  Article CAS PubMed Central  Google Scholar 

• Jadot I, Colombaro V, Martin B, Habsch I, Botton O, Nortier J, Decleves AE, Caron N. Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy. PLoS One. 2017b;12:e0183604.https://doi.org/10.1371/journal.pone.0183604.

  Article CAS PubMed PubMed Central  Google Scholar 

• Jelaković B, Karanović S, Vuković-Lela I, Miller F, Edwards KL, Nikolić J, et al. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int. 2012;81:559–67.

  PubMed  Google Scholar 

• Jelakowic B, Dika Z, Arlt VM, Stiborova M, Pavlovic N, Nikolic J, Colet J-M, Vanherweghem JL, Nortier JL. Balkan endemic nephropathy and the causative role of aristolochic acid. Semin Nephrol. 2019;39:284–96.

  Google Scholar 

• Lemy A, Wissing KM, Rorive S, Zlotta A, Roumeguere T, Muniz-Martinez MC, Decaestecker C, Salmon I, Abramowicz D, Vanherweghem JL, Nortier JL. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. Am J Kidney Dis. 2008;51:471–7.

  PubMed  Google Scholar 

• Lewis CJ, Alpert S. Letter to health care professionals on FDA concerned about botanical products, including dietary supplements containing aristolochic acid. Us Food and Drug Administration – Center for Food Safety and Applied Nutrition – Office of Nutritional Products. Labeling and Dietary supplements, 2000.

  Google Scholar 

• Martinez MC, Nortier J, Vereerstraeten P, Vanherweghem JL. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant. 2002;17:408–12.

  PubMed  Google Scholar 

• Nortier J, Muniz Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux M, Simon J, De Pauw L, Kinnaert P, Abramowicz D, Vereerstraeten P, Vanherweghem J-L. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342:1686–92.

  CAS PubMed  Google Scholar 

• Nortier JL, Roumeguere T. Bladder cancer – a genotoxic causal agent recognized. In: Wild CP, Weiderpass E, Stewart BW, editors. World cancer report: cancer research for cancer prevention. Lyon: International Agency for Research on Cancer; 2020.http://publications.iarc.fr/586.

  Google Scholar 

• Pavlovic NM. Balkan endemic nephropathy – current status and future perspectives. Clin Kidney J. 2013;6:257–65.

  PubMed PubMed Central  Google Scholar 

• Chan W, Pavlovic NM, Li W, Chan CK, Liu J, Deng K, Wang Y, Milosavljevic B, Kostic EN. Quantitation of aristolochic acids in corn, wheat grain, and soil samples collected in Serbia: identifying a novel exposure pathway in the etiology of Balkan endemic nephropathy. J Agric Food Chem. 2016;64:5928–34.

  CAS PubMed  Google Scholar 

• Pozdzik AA, Salmon IJ, Debelle FD, Decaestecker C, Van Den Branden C, Verbeelen D, Deschodt-Lanckman M, Vanherweghem JL, Nortier JL. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 2008a;73:595–607.

  CAS PubMed  Google Scholar 

• Pozdzik AA, Salmon IJ, Husson C, Rogier E, Bourgeade MF, Deschodt-Lanckman M, Vanherweghem JL, Nortier JL. Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol Dial Transplant. 2008b;23:2480–91.

  PubMed  Google Scholar 

• Pozdzik AA, Giordano L, Li G, Antoine M-L, Quellard N, Godet J, De Prez E, Husson C, Decleves AE, Arlt VM, Goujon JM, Brocheriou-Spelle I, Ledbetter SR, Caron N, Nortier JL. Blocking TGF-β signalling pathway preserves mitochondrial proteostasis and reduces early activation of PDGFRβ+ pericytes in aristolochic acid induced acute kidney injury in Wistar male rats. PLoS One. 2016;11:e0157288.https://doi.org/10.1371/journal.pone.0157288.

  Article CAS PubMed PubMed Central  Google Scholar 

• Roumeguere T, Broeders N, Jayaswal A, Rorive S, Quackels T, Pozdzik A, Arlt VM, Schmeiser HH, Nortier JL. BCG therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy. Transpl Int. 2015;28:199–205.

  CAS PubMed  Google Scholar 

• Sborchia M, De Prez E, Antoine M-H, Bienfait L, Indra R, Valbuena G, Phillips DH, Nortier JL, Stiborova M, Keun H, Arlt VM. The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro. Arch Toxicol. 2019;93:3345–66.

  CAS PubMed PubMed Central  Google Scholar 

• Schmeiser HH, Nortier JL, Singh R, Gamboa Da Costa G, Sennesael J, Cassuto-Viguier E, Ambrosetti D, Rorive S, Pozdzik A, Phillips DH, Stiborova M, Arlt VM. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy. Int J Cancer. 2014;135:502–7.

  CAS PubMed  Google Scholar 

• Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem JL. Identification of aristolochic acid in Chinese herbs. Lancet. 1994;343:174.

  CAS PubMed  Google Scholar 

• Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R, Vanhaelen M. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 1993;341:387–91.

  CAS PubMed  Google Scholar 

• Vanherweghem JL, Abramowicz D, Tielemans C, Depierreux M. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am J Kidney Dis. 1996;27:209–15.

  CAS PubMed  Google Scholar 

• Vanherweghem JL. Aristolochia sp and chronic interstitial nephropathies in Indians. Lancet. 1997;349:1399.

  CAS PubMed  Google Scholar 

• Williamson EM, Chan K, Xu Q, Nachtergael A, Bunel V, Zhang L, Ouedrago M, Nortier J, Qu F, Liu X, Stevigny C, Kahumba J, Pelkonen O, Duez P. Evaluating the safety of herbal medicines: integrated toxicological approaches. Science. 2015;347:S47–9.

  Google Scholar 

• World Health Organization - International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: some traditional herbal medicines, some mycotoxins, naphtalene and styrene. IARC Pub. 2002;82:118.

  Google Scholar 

• Yamani A, Bunel V, Antoine M-H, Husson C, Stevigny C, Duez P, Elachouri M, Nortier J. Substitution betweenAristolochia andBryonia genus in North-Eastern Morocco: toxicological implications. J Ethnopharmacol. 2015;166:250–60.

  PubMed  Google Scholar 

• Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med. 2010;16:535–43.

  CAS PubMed PubMed Central  Google Scholar 

• Yang L, Su T, Li XM, et al. Aristolochic acid nephropathy: variation in presentation and prognosis. Nephrol Dial Transplant. 2012;27:292–8.

  CAS PubMed  Google Scholar 

• Yang HY, Wang JD, Lo TC, Chen PC. Occupational kidney disease among Chinese herbalists exposed to herbs containing aristolochic acids. Occup Environ Med. 2011;68:286–90.

  CAS PubMed  Google Scholar 

• Zlotta AR, Roumeguere T, Kuk C, Alkhateeb S, Rorive S, Lemy A, Van Der Kwast TH, Fleshner NE, Jewett MAS, Finelli A, Schulman C, Lotan Y, Shariat SF, Nortier J. Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer. Eur Urol. 2011;59:1026–31.

  PubMed  Google Scholar 

Download references